A Comprehensive Assessment of Trunk, Scapula and Upper Limb in Neurological Patients. Reliability, Validity and Interrelatedness

Last updated: July 11, 2024
Sponsor: Hasselt University
Overall Status: Completed

Phase

N/A

Condition

Stroke

Multiple Sclerosis

Cerebral Ischemia

Treatment

the interaction between trunk, scapula and upper limb impairments.

the prevalence of trunk, scapula and upper limb impairments.

Clinical Scapular protocol (ClinScaP)

Clinical Study ID

NCT04908891
Neuro-JR-001
  • Ages > 18
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

The study aimed to provide insights in the coordination between trunk, shoulder and upper limb while reaching. Two main phases are present in this study:

In phase A: the psychometric properties of two tests: Clinical Scapular protocol (ClinScaP) in PwMS (Persons with Multiple Sclerosis) and healthy controls.

  1. To investigate the test-retest reliability of the Clinical Scapular Protocol (ClinScaP) and the Reaching Performance Scale (RPS) in PwMS

  2. To investigate the discriminative of the ClinScaP between PwMS and healthy controls

  3. To investigate the discriminative of the RPS between PwMS and healthy controls

  4. To investigate the concurrent validity of ClinScaP and RPS in PwMS, compared with upper limb dysfunction measurements.

    In phase B:

  5. To investigate the prevalence of trunk, scapula and upper limb impairments in PwMS and stroke patients.

  6. To investigate the interaction between trunk, scapula and upper limb impairments in PwMS and stroke patients.

Eligibility Criteria

Inclusion

Inclusion criteria for all participants: Healthy controls, PwMS (Persons with Multiple Sclerosis) and stroke patients

  • Age > 18 years

  • Able to understand and execute the test instructions

  • Able to sit on a chair with low back support for 10 minutes

Inclusion criteria specific for PwMS:

  • Diagnosed with MS (Multiple Sclerosis) using McDonald criteria

  • Able to move at least 1 out of 3 joints (wrist, elbow or shoulder): Medical ResearchCouncil score 3.

Inclusion criteria for stroke patients:

  • First- ever single, unilateral (ischemic or hemorrhagic) stroke

  • No apraxia or hemi spatial neglect

  • Able to move at least 1 out of 3 joints of the affected upper limb (wrist, elbow orshoulder): Medical Research Council score 3.

Exclusion

Exclusion Criteria:

  • Other medical conditions interfering with the upper limb function or trunk (orthopedic or rheumatoid impairment)

  • Perceived pain in one of the upper limbs of more than 4/10 (Visual Analog Scale)

  • Severe cognitive or visual deficits interfering with testing

  • For the PwMS: a relapse or relapse-related treatment in the last month prior to thestudy

Study Design

Total Participants: 78
Treatment Group(s): 3
Primary Treatment: the interaction between trunk, scapula and upper limb impairments.
Phase:
Study Start date:
December 12, 2018
Estimated Completion Date:
August 30, 2022

Connect with a study center

  • Ziekenhuis Oost-Limburg

    Genk, 3600
    Belgium

    Site Not Available

  • Jessa Ziekenhuis- Campus St. Ursula

    Herk-de-Stad, 3540
    Belgium

    Site Not Available

  • National MS Center Melsbroek

    Melsbroek, 1820
    Belgium

    Site Not Available

  • Noorderhart MS & Revalidatie

    Overpelt, 3900
    Belgium

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.